Last 48 quarters of trend data · Healthcare · Healthcare Providers
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 21.28 | 20.25 | 16.41 | 12.53 | 18.56 | 25.61 | 22.06 | 17.11 | 19.57 | 22.79 | 19.15 | 18.77 | 19.40 | 19.99 | 18.81 | 15.55 | 16.99 | 25.13 | 22.74 | 16.25 | 14.26 |
| — | -20.9% | -25.6% | -26.8% | -5.2% | +12.4% | +15.2% | -8.8% | +0.9% | +14.0% | +1.8% | +20.7% | +14.1% | -20.5% | -17.3% | -4.3% | +19.2% | +68.5% | +65.7% | +6.8% | -25.4% | |
| P/S Ratio | 2.15 | 1.88 | 1.58 | 1.53 | 1.75 | 2.20 | 2.15 | 1.78 | 1.68 | 1.83 | 1.68 | 1.60 | 1.36 | 1.41 | 1.44 | 1.18 | 1.33 | 1.04 | 1.05 | 1.34 | 0.99 |
| — | -14.4% | -26.4% | -13.7% | +4.2% | +20.4% | +27.8% | +10.8% | +23.8% | +29.4% | +16.6% | +36.3% | +2.5% | +35.2% | +37.1% | -12.0% | +34.4% | -29.5% | -12.8% | +0.8% | -27.2% | |
| P/B Ratio | 4.29 | 3.40 | 2.92 | 2.89 | 3.30 | 4.08 | 4.06 | 3.52 | 3.32 | 3.62 | 3.46 | 3.51 | 2.95 | 3.11 | 3.33 | 2.78 | 3.24 | 2.60 | 1.76 | 2.27 | 2.17 |
| — | -16.6% | -28.0% | -17.9% | -0.3% | +12.7% | +17.3% | +0.2% | +12.5% | +16.4% | +3.9% | +26.3% | -9.0% | +19.6% | +89.4% | +22.3% | +49.4% | -0.2% | -37.6% | -27.7% | -34.1% | |
| P/FCF | 29.84 | 23.75 | 40.56 | 16.14 | 23.19 | 38.81 | 27.65 | 20.60 | 29.49 | 20.50 | 36.16 | 21.23 | — | 24.85 | 19.12 | 10.39 | — | — | 8.95 | 13.66 | — |
| — | -38.8% | +46.7% | -21.6% | -21.3% | +89.3% | -23.5% | -3.0% | — | -17.5% | +89.1% | +104.2% | — | — | +113.7% | -23.9% | — | — | -24.0% | -50.0% | — | |
| EV / EBITDA | 10.69 | 9.67 | 8.48 | 7.94 | 9.08 | 11.97 | 11.12 | 9.35 | 9.73 | 10.84 | 9.98 | 10.07 | 4.66 | 4.82 | 4.80 | 4.15 | 9.26 | 8.83 | 9.22 | 10.44 | 8.77 |
| — | -19.2% | -23.8% | -15.0% | -6.6% | +10.4% | +11.5% | -7.1% | +108.7% | +125.0% | +108.0% | +142.6% | -49.7% | -45.4% | -48.0% | -60.2% | +5.6% | -13.0% | +12.6% | +15.1% | -9.6% | |
| EV / EBIT | 15.44 | 12.79 | 10.91 | 9.64 | 11.67 | 15.56 | 14.11 | 11.97 | 12.88 | 14.25 | 13.07 | 13.09 | 12.64 | 13.37 | 13.09 | 11.25 | 11.94 | 12.78 | 13.54 | 14.67 | 11.52 |
| — | -17.8% | -22.7% | -19.5% | -9.4% | +9.2% | +8.0% | -8.6% | +1.9% | +6.6% | -0.2% | +16.4% | +5.8% | +4.6% | -3.3% | -23.3% | +3.7% | -4.8% | +30.9% | +25.9% | -8.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.2% | 21.6% | 44.5% | 44.4% | 44.0% | 42.5% | 43.0% | 43.3% | 41.7% | 41.3% | 41.7% | 41.5% | 41.1% | 41.0% | 42.0% | 41.2% | 95.3% | 95.3% | 95.5% | 95.3% | 95.9% |
| — | -49.2% | +3.5% | +2.4% | +5.4% | +2.9% | +3.0% | +4.5% | +1.6% | +0.9% | -0.7% | +0.8% | -56.9% | -57.0% | -56.0% | -56.8% | -0.7% | -0.1% | -0.6% | -0.5% | +0.2% | |
| Operating Margin | 17.7% | 17.9% | 18.1% | 19.0% | 18.3% | 16.5% | 17.8% | 18.3% | 16.5% | 15.5% | 16.6% | 15.8% | 35.7% | 35.7% | 36.2% | 36.2% | 15.8% | 13.6% | 14.1% | 14.4% | 13.7% |
| — | +8.5% | +1.6% | +3.6% | +11.0% | +6.5% | +7.3% | +16.4% | -53.7% | -56.6% | -54.2% | -56.5% | +125.8% | +161.8% | +157.0% | +151.5% | +15.6% | -17.5% | -17.3% | -14.7% | -14.0% | |
| Net Margin | 9.5% | 9.3% | 9.6% | 12.3% | 9.5% | 8.6% | 9.7% | 10.4% | 8.6% | 8.0% | 8.8% | 8.5% | 7.0% | 7.1% | 7.7% | 7.6% | 7.9% | 4.2% | 4.6% | 8.3% | 6.9% |
| — | +8.8% | -1.2% | +17.8% | +9.9% | +6.9% | +11.2% | +21.8% | +22.5% | +13.3% | +13.9% | +13.1% | -10.6% | +69.6% | +68.0% | -8.5% | +13.2% | -57.9% | -47.9% | -5.3% | -1.9% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 18.5% | 4.3% | 4.5% | 5.9% | 4.5% | 4.0% | 4.7% | 5.2% | 4.3% | 4.1% | 4.6% | 4.8% | 3.9% | 4.0% | 4.5% | 4.6% | 5.0% | 2.1% | 1.9% | 3.6% | 3.9% |
| — | +5.9% | -4.4% | +11.8% | +4.2% | -2.1% | +2.0% | +9.4% | +11.1% | +2.5% | +1.7% | +4.4% | -21.2% | +89.9% | +135.1% | +28.2% | +26.9% | -52.4% | -63.4% | -32.0% | -10.8% | |
| ROA | 8.3% | 2.0% | 2.1% | 2.7% | 2.1% | 1.9% | 2.1% | 2.3% | 1.9% | 1.7% | 1.8% | 1.8% | 1.5% | 1.4% | 1.6% | 1.5% | 1.6% | 0.7% | 0.7% | 1.3% | 1.3% |
| — | +7.7% | -1.5% | +17.4% | +12.5% | +10.0% | +17.1% | +26.1% | +28.2% | +16.8% | +14.8% | +18.4% | -9.8% | +99.5% | +126.8% | +21.6% | +19.3% | -51.8% | -59.7% | -23.3% | +2.4% | |
| ROIC | 13.9% | 3.5% | 3.5% | 3.8% | 3.6% | 3.2% | 3.5% | 3.6% | 3.2% | 3.0% | 3.1% | 3.0% | 6.6% | 6.6% | 6.9% | 6.7% | 2.8% | 2.1% | 2.0% | 2.0% | 2.4% |
| — | +8.3% | +2.1% | +4.8% | +12.8% | +8.2% | +12.2% | +20.0% | -51.2% | -55.1% | -54.9% | -55.0% | +132.1% | +209.0% | +249.4% | +236.0% | +17.6% | -10.0% | -36.7% | -31.5% | -10.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.83 | 0.79 | 0.82 | 0.83 | 0.83 | 0.84 | 0.87 | 0.92 | 0.95 | 1.03 | 1.16 | 1.21 | 1.28 | 1.34 | 1.43 | 1.36 | 1.61 | 1.69 | 1.39 | 1.29 | 1.45 |
| — | -5.8% | -5.6% | -10.0% | -13.0% | -18.7% | -25.3% | -24.3% | -25.4% | -23.1% | -18.5% | -10.5% | -20.6% | -20.9% | +2.9% | +5.5% | +10.8% | +23.2% | -1.3% | -24.9% | -18.0% | |
| Debt / EBITDA | 1.97 | 7.31 | 7.50 | 7.17 | 7.34 | 8.16 | 7.92 | 7.81 | 8.75 | 9.74 | 10.21 | 10.51 | 5.70 | 5.88 | 5.86 | 5.50 | 12.31 | 14.02 | 16.82 | 15.25 | 14.15 |
| — | -10.5% | -5.3% | -8.1% | -16.1% | -16.2% | -22.4% | -25.7% | +53.5% | +65.7% | +74.3% | +91.0% | -53.7% | -58.1% | -65.2% | -63.9% | -13.0% | -0.9% | +52.9% | +15.9% | +1.9% | |
| Current Ratio | 1.08 | 1.09 | 1.19 | 1.17 | 1.08 | 1.14 | 1.06 | 1.06 | 1.05 | 1.04 | 1.35 | 1.37 | 1.28 | 1.27 | 1.26 | 1.29 | 1.25 | 1.21 | 1.24 | 1.26 | 1.23 |
| — | -4.3% | +12.3% | +10.3% | +2.7% | +9.7% | -21.4% | -22.1% | -17.8% | -18.3% | +7.4% | +6.2% | +3.0% | +4.9% | +1.8% | +2.2% | +1.2% | +5.9% | +15.7% | +2.1% | -7.0% | |
| Quick Ratio | 1.08 | 1.09 | 1.19 | 1.17 | 1.08 | 1.14 | 1.06 | 1.06 | 1.05 | 1.04 | 1.35 | 1.37 | 1.28 | 1.27 | 1.26 | 1.29 | 1.25 | 1.21 | 1.24 | 1.26 | 1.23 |
| — | -4.3% | +12.3% | +10.3% | +2.7% | +9.7% | -21.4% | -22.1% | -17.8% | -18.3% | +7.4% | +6.2% | +3.0% | +4.9% | +1.8% | +2.2% | +1.2% | +5.9% | +15.7% | +2.1% | -7.0% | |
| Interest Coverage | 8.74 | 9.01 | 8.98 | 10.08 | 9.53 | 8.14 | 8.79 | 8.50 | 7.10 | 6.27 | 6.42 | 6.07 | 5.44 | 5.00 | 5.07 | 4.91 | 5.02 | 3.81 | 2.37 | 3.78 | 4.67 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying EHC stock.
Encompass Health Corporation's current P/E is 21.3x. The average P/E over the last 4 quarters is 16.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Encompass Health Corporation's current operating margin is 17.7%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Encompass Health Corporation's business trajectory between earnings reports.